SARS-CoV-2
ELISA, Neutralization
Human
IgG1, kappa
C144
SARS-CoV-2
ELISA, Neutralization
Human
IgG1, kappa
C102
SARS-CoV-2
ELISA, Neutralization
Human
IgG1, kappa
C105
SARS-CoV-2(2019-nCoV)
ELISA, Neutralization
Human
IgG1, kappa
Iv0205
SARS-CoV-2(2019-nCoV)
ELISA, Neutralization
Human
IgA
S309
SARS-CoV-2(2019-nCoV)
ELISA, Neutralization
Human
IgM
S309
SARS-CoV-2
Neutralization
Human
IgG1, kappa
1H1
SARS-CoV-2
Neutralization
Human
IgG1, kappa
5E1#
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Neutralization
Human
IgG1, kappa
S2P6
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
3A1